In this video, Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine, discussed the HAWK and HARRIER study presented at the virtual American Academy of Ophthalmology annual meeting.
Jeff Heier, MD, presented characteristics of patients with and without intraocular inflammation, as well as the efficacy and safety of brolucizumab for patients in the HAWK study.
“Beovu [brolucizumab, Novartis] has been out for the past year now, and we’re looking forward to utilizing this drug for patients ... where
Uncategorized